TScan Therapeutics Reaches Agreement with FDA on Pivotal Study Design for TSC-101 and Announces Strategic Prioritization to Advance TSC-101 and Extend Cash Runway into H2 2027 November 10, 2025
Pyxis Oncology Provides Business Update and Reports Third Quarter 2025 Financial Results November 3, 2025
BBOT Announces Poster Presentations at the San Antonio Breast Cancer Symposium (SABCS) November 3, 2025
Pyxis Oncology Provides Business Update and Reports Third Quarter 2025 Financial Results November 3, 2025
